Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate to prevent bone loss in acute multiple sclerosis
ISRCTN87039596Phase 4Terminated
- Sponsor
- North Bristol NHS Trust
- Start
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 4 trial of zoledronate in multiple sclerosis (MS) (2 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Serum type I collagen C-telopeptides difference at day 7. Started Apr 2009; status: terminated.
02
Drugs
zoledronate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on ISRCTN87039596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87039596.